Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer
Clinical trial NCT04093167 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04093167
- Sponsor
- Canadian Cancer Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-26
- Primary completion
- 2026-12-31
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.